Walbert, the former chairman, president, and CEO of Horizon Therapeutics (NASDAQ:HZNP), brings over three decades of experience in the pharmaceutical industry to BioMarin's board. According to ...

Walbert, the former chairman, president, and CEO of Horizon Therapeutics (NASDAQ:HZNP), brings over three decades of experience in the pharmaceutical industry to BioMarin's board. According to ...

We recently published a list of Paul Singer’s Latest Portfolio: Top 10 Stock Picks. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against ...

Can you give a brief, state of the company overview, biggest strengths, biggest challenges and what does BioMarin need to achieve to drive shareholder value over the next twelve to twenty four months?

In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ ... Singer said in a podcast hosted by the CEO of Norges Bank Investment Management.

During his tenure at BioMarin, Bienaimé steered BioMarin from ... “With nearly three decades experience as CEO, Mr Bienaimé’s proven track record and visionary leadership will inspire ...

“Our operational transformation and strong financial execution in 2024 is the first step in BioMarin’s ambitious multiyear growth plan,” Alexander Hardy, president and CEO, said in a statemen ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

BioMarin's chief executive Alexander Hardy – who took the helm of the company after the departure of former CEO Jean-Jacques Bienaimé last December – described Friberg as "a world-class ...